Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III add-on inhaled tobramycin (Gernebcin) in severe COPD
2006-002933-18Phase 3Completed
- Sponsor
- InfectoPharm
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Inhaled tobramycin add-on with Placebo add-on (2 arms). Primary endpoint: Frequency of COPD-exacerbation–related hospitalizations per patient-year at risk. Started May 2008; status: completed.
02
Drugs
tobramycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-002933-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002933-18.